Nanoencapsulated Quercetin Improves Cardioprotection during Hypoxia-Reoxygenation Injury through Preservation of Mitochondrial Function

Figure 7

Protection of PLGA-quercetin against H-R in H9c2 cells: (a) basal OCR; (b) maximum ETC capacity; (c) mitochondrial membrane potential; (d) ATP production. All quercetin or PLGA-quercetin were done at 5 μM. Statistical significance versus NT cells denoted as , for H-R cells denoted as ^a, for quercetin-treated cells denoted by ^b, and for PLGA-quercetin-treated cells denoted by ^c, means .

(a)

(b)

(c)

(d)